10x Genomics to report Q3 2026 earnings on Nov 5 with a live webcast for investors.

10x Genomics, a leader in life science technology, will announce its financial results for the third quarter ending September 30, 2026, after market close on November 5, 2026. The company will hold a public conference call and webcast at 1:30 p.m. PT to discuss its earnings, business updates, and future outlook. Investors can access the webcast live on the company's website, with a replay available for 45 days. This earnings report will provide insights into 10x Genomics' progress in advancing biological research and health technologies.

As 10x Genomics prepares to report its Q3 2026 results on November 5, the stock is currently trading at USD 71.71 on Pluang as of October 14, 2026, 03:11 WIB, down 4.63% for the day. This price sits well below its 52-week high of USD 97.74 but remains significantly above the 52-week low of USD 11.54. Investor interest appears strong with 100% buy orders and a typical hold time of 92 days, indicating confidence ahead of the earnings announcement.